Michiana Hematology Oncology (MHO) is a leading provider of cancer care services in northern Indiana, with a focus on bringing world-class cancer care to the region. Established in 1968, MHO stands out as the largest team of board-certified oncologists in northern Indiana, specializing in treating a wide range of cancers and blood disorders, including breast, lung, gynecologic, prostate, and colon cancer.
The company's mission revolves around treating the whole person - body, mind, and spirit, and it prides itself on offering personalized, compassionate, and affordable community cancer care. MHO is committed to healing the whole person, inspiring hope, and enhancing the quality of life for all its patients, while providing the most progressive and affordable cancer care in the communities it serves.
With a strong focus on health care and wellness, MHO's approach goes beyond traditional treatment methods to support and empower patients. While specific details about the company's headquarters location and recent investments are not available, MHO's dedication to providing exceptional cancer care and its long-standing presence in the industry make it an attractive potential investment opportunity for venture capitalists looking to support impactful healthcare startups.
There is no investment information
No recent news or press coverage available for Michiana Hematology Oncology (MHO).